Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced the deployment of AI models for patient identification of patients living wit...
Atropos Health’s platform, including GENEVA OS™ and the Atropos Evidence™ Network Launches AI Model for Precision Medicine at Scale
PALO ALTO, Calif.: Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced the deployment of AI models for patient identification of patients living with undiagnosed conditions. The AI models will be deployed to clinicians by members of the Atropos Evidence™ Network.
Atropos Health AI-built models are developed, trained, and tested using real-world data (RWD) from the Atropos Evidence Network to reduce the time from initial symptom to testing, diagnosis and treatment at the point of care. The models are created by Atropos Health medical doctors, epidemiologists, statisticians, and Masters / Phd level personnel. Implementing the models will save practicing clinicians time and improve patient experience by identifying conditions earlier and reducing time to treatment.
"Increasing the speed, inclusivity and accuracy of precision medicine is the power of Generative AI in practice," said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. "By utilizing the portfolio of Atropos Health services such as GENEVA OS and the Atropos Evidence Network, precision medicine based on RWE is becoming a reality and reducing the time from symptom to treatment leads to better outcomes for patients and better experiences for providers."
Customers rely on Atropos Health’s portfolio of evidence-generation tools and the Atropos Evidence™ Network, the industry’s largest federated healthcare data network, with over 300 million patient records, to accelerate precision medicine. Atropos Evidence Network members can access more RWD and the right data for each question backed by the Real World Fitness Score™ (RWFS), which evaluates the appropriateness and quality of data for each question. These additional datasets also increase the opportunity for partners to find more “fit-for-purpose” data. Atropos Evidence Network members also benefit from the ability to leverage network members, such as Arcadia, to deliver AI models to clinicians.
Atropos Health is collaborating with Arcadia to help leading healthcare organizations deliver the latest care protocols and advanced precision medicine at scale. The partnership between Arcadia and Atropos Health enables healthcare providers to accelerate clinical decision-making with actionable, AI-powered insights at the point of care using the combination of real-world evidence and longitudinal patient records to improve outcomes and drive high-value, low-cost care.
Life sciences companies are engaged with Atropos Health on leveraging AI for precision medicine and today’s announcement comes on the heels of Atropos Health launching AI tools for Atropos Evidence™ Network members and the growth of the Atropos Evidence Network. The Atropos Evidence Network already includes an impressive slate of leaders in the healthcare data ecosystem and recently added Forian, Syndesis Health, and Norstella. Atropos Health offers automation and standardization of AI model training, testing, and deployment to healthcare AI developers. AI developers can now build at scale and meet emerging AI assurance standards, putting their technology to use to improve patient outcomes. The Data Quality ScoreCard provides data holder members of the Atropos Evidence Network a confidential way to measure, evaluate, compare, and benchmark their data quality based on objective criteria, underscoring the importance of data quality and transparency in methodology.
About Atropos Health
Atropos Health is the developer of GENEVA OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.
To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X (Twitter) @AtroposHealth.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group,” “we” or “our”), a leading provider of online real estate marketplaces, information and analytics in…
BJ’s Wholesale Club (NYSE: BJ) announced today that its club in Brooksville, Florida, will open on February 21, 2025. The club, located at 13085 Cortez…
University of Phoenix College of Doctoral Studies has released a new white paper, “Economic Influence of AI on Career Optimism,” by Christine Marquis,…
Qurate Retail, Inc. (Nasdaq: QRTEA, QRTEB, QRTEP) today announced that an authorized committee of its Board of Directors declared the regular quarterly…